Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases

Surgical Treatment of Metastatic Colorectal Cancer

(2018) Jeffery Chakedis et al.   Surgical Oncology Clinics of North America

Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential

(2017) Linda M. Pak et al.   JOURNAL OF SURGICAL ONCOLOGY

Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer

(2017) Elizabeth M. Cespedes Feliciano et al.   JAMA Oncology

Colon Cancer, Version 3.2014

(2017) Al B. Benson et al.   Journal of the National Comprehensive Cancer Network

Hepatic Arterial Infusion in Combination with Modern Systemic Chemotherapy is Associated with Improved Survival Compared with Modern Systemic Chemotherapy Alone in Patients with Isolated Unresectable Colorectal Liver Metastases: A Case–Control Study

(2016) Mashaal Dhir et al.   ANNALS OF SURGICAL ONCOLOGY

SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer

(2016) Guy A. van Hazel et al.   JOURNAL OF CLINICAL ONCOLOGY

Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies

(2016) Andrea Cercek et al.   JOURNAL OF SURGICAL ONCOLOGY

Hepatic Artery Infusional Chemotherapy

(2016) Heather L. Lewis et al.   SURGICAL CLINICS OF NORTH AMERICA

Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer

(2015) Michael I. DʼAngelica et al.   ANNALS OF SURGERY

A systematic review and meta-analysis to reappraise the role of adjuvant hepatic arterial infusion for colorectal cancer liver metastases

(2015) Wei Liu et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?

(2015) Toine M. Lodewick et al.   HPB

Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer

(2015) Yuji Miyamoto et al.   PLoS One

Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-Analysis

(2015) Anthony J. Zacharias et al.   PLoS One

Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement

(2014) P.J. Karanicolas et al.   Current Oncology

Floxuridine Hepatic Arterial Infusion Associated Biliary Toxicity Is Increased by Concurrent Administration of Systemic Bevacizumab

(2013) Andrea Cercek et al.   ANNALS OF SURGICAL ONCOLOGY

Conversion to Complete Resection and/or Ablation Using Hepatic Artery Infusional Chemotherapy in Patients with Unresectable Liver Metastases from Colorectal Cancer: A Decade of Experience at a Single Institution

(2013) John B. Ammori et al.   ANNALS OF SURGICAL ONCOLOGY

Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index

(2013) Lisa Martin et al.   JOURNAL OF CLINICAL ONCOLOGY

Body composition and outcome in patients undergoing resection of colorectal liver metastases

(2012) M. G. van Vledder et al.   BRITISH JOURNAL OF SURGERY

Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)

(2012) Hans-Joachim Schmoll et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluation of the Clinical Relevance of Body Composition Parameters in Patients With Cancer Metastatic to the Liver Treated With Hepatic Arterial Infusion Chemotherapy

(2012) Henrique A. Parsons et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Comparison of Adjuvant Systemic Chemotherapy With or Without Hepatic Arterial Infusional Chemotherapy After Hepatic Resection for Metastatic Colorectal Cancer

(2011) Michael G. House et al.   ANNALS OF SURGERY

Pro-inflammatory and tumour proliferative properties of excess visceral adipose tissue

(2011) J. Lysaght et al.   CANCER LETTERS

Hepatic Arterial Infusion and Systemic Chemotherapy After Multiple Metastasectomy in Patients With Colorectal Carcinoma Metastatic to the Liver: A North Central Cancer Treatment Group (NCCTG) Phase II Study, 92-46-52

(2011) John S. Bolton et al.   Clinical Colorectal Cancer

Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) Phase II Intergroup Trial, N9945/CI-66

(2010) Steven R. Alberts et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Hepatic Metastases From Colorectal Cancer

(2010) Nancy E. Kemeny et al.   JOURNAL OF CLINICAL ONCOLOGY

Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma

(2009) Nancy E. Kemeny et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials

(2008) Emmanuel Mitry et al.   JOURNAL OF CLINICAL ONCOLOGY

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

(2008) Carla MM Prado et al.   LANCET ONCOLOGY